Voyager Therapeutics Inc.

VYGR | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.12

+$0.04 (+1.30%)

Sep 22, 2026, 12:15 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-119.72M	-65M	132.33M	-46.41M	-71.2M	36.74M
Depreciation & Amortization	4.06M	4.73M	4.44M	6.19M	5.17M	3.82M
Stock-Based Compensation	14.79M	14.79M	11.15M	9.34M	11.32M	14.93M
Other Working Capital	-30.05M	-48.84M	17.64M	18M	-3.93M	-151.59M
Other Non-Cash Items	-2.83M	-4.68M	-3.45M	-2.11M	-2.11M	-7.67M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-28.76M	34.86M	-66.56M	20.47M	3.29M	-144.54M
Operating Cash Flow	-132.47M	-15.31M	77.92M	-12.51M	-53.53M	-96.72M
Capital Expenditures	-2.6M	-3.52M	-3.26M	-2.49M	-1.61M	-12.1M
Cash Acquisitions	n/a	n/a	138.39M	n/a	n/a	n/a
Purchase of Investments	-133.93M	-465.69M	-223.97M	-54.85M	-15.12M	-70.4M
Sales Maturities Of Investments	261.97M	374.35M	85.58M	50M	82.63M	195.5M
Other Investing Acitivies	n/a	n/a	-138.39M	n/a	n/a	n/a
Investing Cash Flow	125.45M	-94.86M	-141.64M	-7.34M	65.91M	113M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	3.16M
Financial Cash Flow	816K	114.02M	33.65M	1.11M	612K	3.16M
Net Cash Flow	-6.21M	3.85M	-30.08M	-18.47M	12.99M	18.4M
Free Cash Flow	-135.06M	-18.83M	74.66M	-15M	-55.13M	-108.81M
Adj. Free Cash Flow	-149.85M	-33.62M	63.51M	-24.34M	-66.46M	-123.75M
Maintenance CapEx	-2.6M	-3.52M	n/a	-430.79K	-1.61M	n/a
Growth CapEx	n/a	n/a	-3.26M	-2.06M	n/a	-12.1M
Owner Earnings	-135.06M	-18.83M	77.92M	-12.94M	-55.13M	-96.72M